Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01979523
Title Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

uveal melanoma



Trametinib + Uprosertib

Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Columbia University/Herbert Irving Cancer Center New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Institut Curie Paris Paris 75005 France Details
The University of Liverpool Liverpool L69 3GA United Kingdom Details
*Shaded cells indicate that there was no data available from for the field